Clinical trials in Germany
28,747 studies list at least one site in Germany. 3,681 are recruiting or about to start. Per ClinicalTrials.gov, last updated 2026-11-10.
Status
Most studied here
Who runs them
Novartis Pharmaceuticals (1,029) · Charite University, Berlin, Germany (809) · Boehringer Ingelheim (747) · AstraZeneca (636) · GlaxoSmithKline (634) · Hoffmann-La Roche (596) · Bayer (547) · University Hospital Tuebingen (445)
What changed recently
From the registry's own updates since Oct 11, 2026.
Started recruiting52
- Effects of rTMS Compared to SSRI as Early Treatment of Depression (Early-TMS)Nov 10, 2026NCT06545474
- A Study of KarXT + KarX-EC for Treatment of Irritability in Children and Adolescents With Autism Spectrum DisorderNov 10, 2026NCT07285798
- Efficacy of Asciminib in Chronic Phase CML Patients With T315I MutationsNov 10, 2026NCT07789574
- Observational Study With CICR-NAM as a Food for Special Medicinal Purposes in Post-COVID Syndrome (PCS)Nov 10, 2026NCT07798570
- A Research Study to Check the Safety of NNC9836-0001 When Given to Healthy Participants and Participants With Type 2 DiabetesNov 10, 2026NCT07896109
Show 45 moreShow fewer
- Multi-peptide Vaccination Adjuvanted With XS15 in Acute Myeloid Leukemia PatientsNov 9, 2026NCT06252584
- Observational Study to Collect Data of Patient Which Recieving a TAVI in TAVI ProcedureNov 9, 2026NCT07215143
- Routine Microaxial Heart Pump Support and Protocolized Pulmonary Artery Catheter Monitoring Versus Standard Care in Heart Attack-Related Cardiogenic ShockNov 9, 2026NCT07762560
- A Study to Assess the Efficacy and Safety of Pegcetacoplan for the Prevention of Recurrent C3G or Primary IC-MPGN in Kidney Transplant RecipientsNov 9, 2026NCT07898774
- A Study of Mezagitamab in Adults With Late Antibody-Mediated Rejection (AMR) After a Kidney TransplantNov 6, 2026NCT07613359
- Magnetic Field Maps With NV Application Kit MCGNov 6, 2026NCT07908173
- Holistic Assessment and Remote Digital MONitoring of mYasthenia Gravis Via MyoSense 360Nov 5, 2026NCT07323316
- IMPLEMENTING PATIENTS' COMPETENCE IN ORAL EBC THERAPY PERSISTENCENov 4, 2026NCT07521202
- First-Line Luspatercept in Transfusion-Dependent Lower-Risk Myelodysplastic NeoplasmsNov 4, 2026NCT07752121
- A Study of EloraTZP in Adult Participants With Obesity or Overweight and Type 2 DiabetesNov 4, 2026NCT07881458
- A Study to Learn How Well Lucerastat Works and How Safe it is in Untreated Adult Male Participants With Fabry DiseaseNov 3, 2026NCT07778667
- Safety, Tolerability And Pharmacodynamics of DM-101PX in Birch Pollen AllergyNov 3, 2026NCT07898800
- Achieving Optimal Medical Therapy Through Percutaneous Treatment of Secondary Mitral Regurgitation to Improve Outcome in Patients With HFrEFNov 2, 2026NCT07758023
- Safety and Performance of a Pelvic Floor Mesh Implant for Laparoscopic Sacrocolpopexy (ProGYNious)Oct 30, 2026NCT07497321
- Designing a Large Language Model Architecture for Shared Decision Making and Informed IntentionsOct 30, 2026NCT07827924
- SYMmetric Valve fraME Expansion To Reduce hYpoattenuated Leaflet Thickening After Balloon-expandable TAVI: the SYMMETRY TrialOct 30, 2026NCT07872020
- International Phase I Trial of Dinutuximab Beta With VDC/IE in GD2-Positive Ewing SarkomaOct 29, 2026NCT06839703
- Beamion LUNG-1: A Study to Test Different Doses of Zongertinib in People With Different Types of Advanced Cancer (Solid Tumours With Changes in the HER2 Gene)Oct 28, 2026NCT04886804
- Rectus Sheath Catheters Following Midline LaparotomyOct 28, 2026NCT07099924
- Gastroduodenal Full Thickness Resection Device Registry - gdFTRD® RegistryOct 28, 2026NCT07142902
- A Research Study Investigating Denecimig (Mim8) in Adults With Acquired Haemophilia AOct 28, 2026NCT07830732
- Breisgau PHENO-HEART MIOct 27, 2026NCT06166407
- Surgical Treatment of Adjacent Segment StenosisOct 27, 2026NCT07661199
- CRP Apheresis in Infarct-Related Cardiogenic ShockOct 27, 2026NCT07687017
- Multimodal Characterization of Movement Trajectories in Chronic Inflammatory Demyelinating PolyneuropathyOct 27, 2026NCT07882797
- International Study for Treatment of Childhood Relapsed Precursor B-Cell ALL 2020 (IntReALL BCP 2020)Oct 26, 2026NCT07476729
- Renal Impairment Pharmacokinetics (PK) Trial of AfabicinOct 26, 2026NCT07758608
- Prevent Cognitive Decline in GBA-associated Parkinson's DiseaseOct 23, 2026NCT07055087
- Reliability of Multiple-Repetition-Maximum Tests in Patients With Cardiovascular Disease or Risk FactorsOct 22, 2026NCT06796582
- Study to Evaluate the Safety, Pharmacology and Efficacy of WIN378 in Adults With Moderate or Severe AsthmaOct 21, 2026NCT07120503
- A Phase III, Multicentre Study to Evaluate Consolidation Treatment With AZD0120 Compared With ASCT, in Participants With Newly Diagnosed Multiple Myeloma Who Are Transplant Eligible (DURGA-6).Oct 21, 2026NCT07735637
- Cisplatin-induced Cochlear and Vestibular Damage in Head and Neck CancerOct 20, 2026NCT06929468
- Framework for Optimizing, Refining, and Unifying Management of HSCT in Pediatric ALLOct 20, 2026NCT07297914
- A Study to Learn More About the Treatment of People With Congenital Thrombotic Thrombocytopenic Purpura (cTTP) Who Received Recombinant ADAMTS13 (rADAMTS13) as Part of the Early Access ProgramOct 20, 2026NCT07429942
- A Phase 1b/2a, Open-label Single Ascending Doses and Multiple Ascending Doses Study in Participants With Pi*ZZ AATDOct 19, 2026NCT06405633
- A Study to Learn How Men With Advanced Prostate Cancer Respond to Treatment With Darolutamide and Hormone Therapy, With or Without Chemotherapy, in Real-world Medical PracticeOct 19, 2026NCT07344779
- Edge-to-edge Mitral Valve Repair in ATTR-CMOct 16, 2026NCT06075823
- A Study to Assess the Effectiveness and Safety of Pacritinib in Patients With VEXAS Syndrome (PAXIS)Oct 16, 2026NCT06782373
- A Trial of Inebilizumab in Participants With Autoimmune HepatitisOct 16, 2026NCT07598825
- Torvutatug Samrotecan With or Without Bevacizumab as Maintenance Treatment of Platinum-sensitive Relapsed Epithelial Ovarian CancerOct 16, 2026NCT07816666
- A Study to Test Whether BI 764524 Helps People With an Eye Condition Called Diabetic RetinopathyOct 15, 2026NCT06321302
- Prevention-in-PD-StudyOct 15, 2026NCT07297407
- Saruparib in Combination With Physician's Choice of ARPI in Patients With mHSPC Previously Treated With Docetaxel or 177Lu-PSMA Therapy Without Disease Progression and PSA ≥ 0.2 ng/mL (EvoPAR-PR05)Oct 15, 2026NCT07711002
- A Study in Healthy People to Compare How 2 Different Formulations of Vicadrostat / Empagliflozin Tablets Are Taken up in the BodyOct 15, 2026NCT07845630
- A Study to Assess Zipalertinib Versus Placebo in Participants With Early Stage NSCLC With Uncommon EGFR Mutations, Following Complete Tumor ResectionOct 13, 2026NCT07128199
and 2 more not listed
First site in Germany61
- A Study to Evaluate the Efficacy and Safety of QVM149 (Indacaterol Acetate / Glycopyrronium Bromide / Mometasone Furoate) Versus Salmeterol Xinafoate/Fluticasone Propionate in Children From 12 Years to Less Than 18 Years of Age With Asthma.Nov 10, 2026NCT05776927
- Safety, Tolerability, Pharmacokinetics, and Preliminary Efficacy of SPL84 in Patients With Cystic FibrosisNov 10, 2026NCT06429176
- Effects of rTMS Compared to SSRI as Early Treatment of Depression (Early-TMS)Nov 10, 2026NCT06545474
- Study of an Injectable Regimen of GS-3242 With Lenacapavir Compared to Biktarvy in People New to HIV-1 TreatmentNov 10, 2026NCT07708727
- Observational Study With CICR-NAM as a Food for Special Medicinal Purposes in Post-COVID Syndrome (PCS)Nov 10, 2026NCT07798570
Show 45 moreShow fewer
- Secukinumab Open Label Roll-over Extension ProtocolNov 9, 2026NCT04638647
- Multi-peptide Vaccination Adjuvanted With XS15 in Acute Myeloid Leukemia PatientsNov 9, 2026NCT06252584
- Avapritinib Rollover StudyNov 9, 2026NCT06748001
- General Anesthesia vs Conscious Sedation for Radial Endobronchial UltrasoundNov 9, 2026NCT06950515
- Observational Study to Collect Data of Patient Which Recieving a TAVI in TAVI ProcedureNov 9, 2026NCT07215143
- Long-Term Outcomes of Teplizumab in Routine Clinical CareNov 9, 2026NCT07360080
- A Study to Evaluate the Efficacy and Safety of Divarasib Compared With Investigator's Choice of Immunotherapy or Observation in Participants With Resected Stage II-III KRAS G12C-Positive Non-Small Cell Lung Cancer (NSCLC)Nov 9, 2026NCT07541170
- Two Arm, Double-blind, Phase III Study Assessing Efficacy and Safety of Ianalumab Versus Placebo, in Participants With Sjögren's Disease With High Symptom BurdenNov 9, 2026NCT07621809
- A Study to Evaluate the Efficacy and Safety of Rozanolixizumab in Adult Participants With Ocular Myasthenia GravisNov 6, 2026NCT07463521
- Magnetic Field Maps With NV Application Kit MCGNov 6, 2026NCT07908173
- Inari VISION RegistryNov 5, 2026NCT06600542
- A Study to Learn About Study Medicine Called PF-08049820 in People With EczemaNov 5, 2026NCT07216027
- A Study of Fludarabine Dosing in Children and Young Adults With B-cell Acute Lymphoblastic LeukemiaNov 5, 2026NCT07223021
- Holistic Assessment and Remote Digital MONitoring of mYasthenia Gravis Via MyoSense 360Nov 5, 2026NCT07323316
- A Study of Orelabrutinib in Patients With Secondary Progressive Multiple SclerosisNov 4, 2026NCT07299019
- Comparative Efficacy of Nipocalimab and Efgartigimod in Participants With Generalized Myasthenia GravisNov 3, 2026NCT07217587
- A Study to Evaluate the Effectiveness and Safety of Setidegrasib, Given With Either mFOLFIRINOX or NALIRIFOX Chemotherapies, in People With Pancreatic CancerNov 3, 2026NCT07409272
- Study to Assess the Efficacy and Safety of Rina-S in Participants With Advanced Gastrointestinal (GI) CancersNov 3, 2026NCT07539311
- A Trial of Inebilizumab in Participants With Autoimmune HepatitisNov 3, 2026NCT07598825
- A Study of Ramantamig Plus Daratumumab Versus Daratumumab, Bortezomib, Lenalidomide, and Dexamethasone (DVRd) or Daratumumab, Lenalidomide, and Dexamethasone (DRd) in Participants With NDMM For Whom Stem Cell Transplant is Not PlannedNov 3, 2026NCT07665450
- A Study to Learn How Well Lucerastat Works and How Safe it is in Untreated Adult Male Participants With Fabry DiseaseNov 3, 2026NCT07778667
- Study to Evaluate the Efficacy, Safety, and Tolerability of PIPE 791 in Subjects With Idiopathic Pulmonary FibrosisNov 2, 2026NCT07284459
- Achieving Optimal Medical Therapy Through Percutaneous Treatment of Secondary Mitral Regurgitation to Improve Outcome in Patients With HFrEFNov 2, 2026NCT07758023
- Designing a Large Language Model Architecture for Shared Decision Making and Informed IntentionsOct 30, 2026NCT07827924
- Pancreatic Cancer Early Detection ConsortiumOct 29, 2026NCT04970056
- International Phase I Trial of Dinutuximab Beta With VDC/IE in GD2-Positive Ewing SarkomaOct 29, 2026NCT06839703
- Study of Trastuzumab Deruxtecan With Bevacizumab Versus Bevacizumab Monotherapy for First-line Maintenance in HER2-Expressing Ovarian Cancer (DESTINY-Ovarian01)Oct 28, 2026NCT06819007
- Breisgau PHENO-HEART MIOct 27, 2026NCT06166407
- An Open-Label Extension Study of Treprostinil Palmitil Inhalation Powder (TPIP) in Participants With Pulmonary Hypertension Associated With Interstitial Lung Disease (PH-ILD)Oct 27, 2026NCT07234032
- VRAS (Velys Robot-Assisted Solution) Operational Excellence StudyOct 23, 2026NCT06563843
- A Study to Evaluate Safety, Pharmacokinetics, and Activity of GDC-7035 as a Single Agent and in Combination in Patients With Advanced Solid TumorsOct 23, 2026NCT06619587
- Real-World Data Collection of GORE Devices Used In the Endovascular Treatment of Aortic Aneurysms Which Incorporate Visceral Arteries.Oct 23, 2026NCT07480395
- A Phase 1 Study of JADE201 in Participants With Rheumatoid ArthritisOct 23, 2026NCT07533955
- A Study to Investigate the Safety and Effectiveness of SAR448851 in Participants With Early Alzheimer's DiseaseOct 23, 2026NCT07688213
- A Study of CLN-978, a Subcutaneously Administered CD19-directed T Cell Engager, in Subjects With Systemic Lupus ErythematosusOct 22, 2026NCT06613360
- Reliability of Multiple-Repetition-Maximum Tests in Patients With Cardiovascular Disease or Risk FactorsOct 22, 2026NCT06796582
- A Study to Learn About the Study Medicine Called PF-07275315 in People With Moderate to Severe Chronic Obstructive Pulmonary DiseaseOct 22, 2026NCT07363694
- Prevail Global StudyOct 21, 2026NCT06535854
- A Safety and Efficacy Study of EIK1001 in Combination With Pembrolizumab and Chemotherapy in Participants With Stage 4 Non-Small Cell Lung Cancer.Oct 20, 2026NCT07365319
- A Study to Learn More About the Treatment of People With Congenital Thrombotic Thrombocytopenic Purpura (cTTP) Who Received Recombinant ADAMTS13 (rADAMTS13) as Part of the Early Access ProgramOct 20, 2026NCT07429942
- Bronchoscopic RElease of Air Trapped in Hyperinflated Emphysematous Lung - Study 3Oct 19, 2026NCT06891755
- Breathing-Maneuver-Induced Myocardial Oxygenation Reserve Validated by FFR (B-MORE)Oct 16, 2026NCT04126148
- Edge-to-edge Mitral Valve Repair in ATTR-CMOct 16, 2026NCT06075823
- A Phase III Trial of BNT324 Versus Docetaxel in Metastatic Castration-resistant Prostate CancerOct 16, 2026NCT07365995
- A Study to Assess Efficacy and Safety of Efgartigimod PH20 SC PFS in Adult Participants With Graves' Disease.Oct 16, 2026NCT07596849
and 11 more not listed
Results posted46
- Pegcetacoplan Long Term Safety and Efficacy Extension StudyNov 10, 2026NCT03531255
- Study of Belantamab Mafodotin Plus Standard of Care (SoC) in Newly Diagnosed Multiple MyelomaNov 9, 2026NCT04091126
- A Study of Tiragolumab in Combination With Atezolizumab Compared With Placebo in Combination With Atezolizumab in Patients With Previously Untreated Locally Advanced Unresectable or Metastatic PD-L1-Selected Non-Small Cell Lung CancerNov 9, 2026NCT04294810
- A Study on the Reactogenicity, Safety, Immune Response, and Efficacy of a Targeted Immunotherapy Against HSV in Healthy Participants Aged 18-40 Years or in Participants Aged 18-60 Years With Recurrent Genital HerpesNov 9, 2026NCT05298254
- Effect of Food on Peposertib PKNov 6, 2026NCT04702698
Show 41 moreShow fewer
- A Study to Assess Change in Disease Activity, Adverse Events, and How the Drug Moves Through the Body in Adult Participants Living With Human Immunodeficiency Virus (HIV) Receiving Intravenous (IV) Infusion or Subcutaneous (SC) Injection of Budigalimab and/or ABBV-382Nov 6, 2026NCT06032546
- A Study of Nipocalimab in Adults With Primary Sjogren's Syndrome (pSS)Nov 5, 2026NCT04968912
- A Study to Evaluate the Efficacy and Safety of Povorcitinib (INCB054707) in Participants With Moderate to Severe Hidradenitis Suppurativa (HS)Nov 5, 2026NCT05620836
- Study to Compare Bictegravir/Lenacapavir Versus Current Therapy in People With HIV-1 Who Are Successfully Treated With BiktarvyNov 5, 2026NCT06333808
- Ravulizumab in Thrombotic Microangiopathy After Hematopoietic Stem Cell TransplantNov 4, 2026NCT04543591
- Study of Efficacy and Safety of LNP023 in Primary IgA Nephropathy PatientsNov 4, 2026NCT04578834
- An International Prospective Open-label, Randomized, Phase III Study Comparing 177Lu-PSMA-617 in Combination With Standard of Care (SoC), Versus SoC Alone, in Adult Male Patients With Metastatic Hormone Sensitive Prostate Cancer (mHSPC)Nov 4, 2026NCT04720157
- Lead EvaluAtion for Defibrillation and Reliability (LEADR) / Lead Evaluation for Defibrillation and Reliability in Left Bundle Branch Area Pacing (LEADR LBBAP)Nov 4, 2026NCT04863664
- Efficacy and Safety of KBP-5074 in Uncontrolled Hypertension and Moderate or Severe Chronic Kidney Disease (CKD)Nov 4, 2026NCT04968184
- A Phase 3 Trial of Epcoritamab vs Investigator's Choice Chemotherapy in Relapsed/Refractory (R/R) Diffuse Large B-cell Lymphoma (DLBCL)Nov 3, 2026NCT04628494
- Phase 2 Study of SAR444656 in Adult Participants With Moderate to Severe Atopic DermatitisNov 3, 2026NCT06058156
- Double-blind, Randomized, Placebo-controlled, Prospective Phase III Study Evaluating Efficacy and Safety of Panzyga in Primary Infection Prophylaxis in Patients With Chronic Lymphocytic Leukemia ("PRO-SID" Study)Nov 2, 2026NCT04502030
- Research Study to Look at How Well Semaglutide Works in People Living With Heart Failure, Obesity and Type 2 DiabetesNov 2, 2026NCT04916470
- A Study to Learn About the Effect of Nusinersen (BIIB058) Given as Injections to Children With Spinal Muscular Atrophy (SMA) Who Were Previously Treated With Onasemnogene Abeparvovec (RESPOND)Oct 30, 2026NCT04488133
- A Study Evaluating the Efficacy, Safety, Pharmacokinetics and Pharmacodynamics of Crovalimab in Adult and Adolescent Participants With Atypical Hemolytic Uremic Syndrome (aHUS)Oct 30, 2026NCT04861259
- Tiotropium/Salmeterol Inhalation Powder (Spiriva Handihaler and Salmeterol Polyethylene (PE) Capsule) in Chronic Obstructive Pulmonary Disease (COPD)Oct 29, 2026NCT00662740
- ARTEMIS: Ravulizumab to Protect Patients With CKD From CSA-AKI and MAKEOct 29, 2026NCT05746559
- Effects of Maintenance Cabozantinib+BSC Versus BSC in Children and AYA With OsteosarcomaOct 29, 2026NCT06341712
- Efficacy and Safety of Erenumab in Pediatric Subjects With Chronic MigraineOct 28, 2026NCT03832998
- An Extension Study to Evaluate the Long-term Safety and Efficacy of Pegcetacoplan (APL-2) in Subjects With Geographic Atrophy Secondary to AMDOct 28, 2026NCT04770545
- Evaluation of Rifaximin SSD for Delaying Encephalopathy Decompensation in Patients With CirrhosisOct 28, 2026NCT05297448
- A Study to Evaluate Astegolimab in Participants With Chronic Obstructive Pulmonary DiseaseOct 28, 2026NCT05595642
- A Study to Evaluate AZD2693 in Participants Who Are Carriers of the PNPLA3 148M Risk Allele With Non-cirrhotic Non-alcoholic Steatohepatitis With FibrosisOct 28, 2026NCT05809934
- Evaluation of Safety, Tolerability, and Efficacy of INZ-701 in Adults With ENPP1 DeficiencyOct 27, 2026NCT04686175
- A Study of AZD3427 in Participants With Heart Failure and Pulmonary Hypertension Group 2Oct 27, 2026NCT05737940
- A Study to Learn How Well the Study Treatment Finerenone Works and How Safe it is in People With Long-term Decrease in the Kidneys' Ability to Work Properly (Chronic Kidney Disease) Together With Type 1 DiabetesOct 27, 2026NCT05901831
- EAGLE Trial CADDIE Artificial Intelligence EndoscopyOct 26, 2026NCT05730192
- Study of Pembrolizumab (MK-3475) Plus Chemotherapy vs Placebo Plus Chemotherapy as Neoadjuvant Therapy and Pembrolizumab vs Placebo as Adjuvant Therapy in Participants With Triple Negative Breast Cancer (TNBC) (MK-3475-522/KEYNOTE-522)Oct 22, 2026NCT03036488
- Study to Compare Bictegravir/Lenacapavir Versus Current Therapy in People With HIV-1 Who Are Successfully Treated With a Complicated Regimen (ARTISTRY-1)Oct 21, 2026NCT05502341
- A Study of Ustekinumab in Pediatric Participants With Moderately to Severely Active Ulcerative Colitis (UC)Oct 20, 2026NCT04630028
- A Study of Rusfertide in Adults With Polycythemia Vera (PV)Oct 19, 2026NCT05210790
- A Study to Evaluate the Efficacy and Safety of Astegolimab in Participants With Chronic Obstructive Pulmonary DiseaseOct 16, 2026NCT05037929
- A Study of Orforglipron (LY3502970) Compared With Dapagliflozin in Adult Participants With Type 2 Diabetes and Inadequate Glycemic Control With MetforminOct 16, 2026NCT06192108
- Multinational Study of Efficacy and Safety of Inhaled Treprostinil in Subjects With Idiopathic Pulmonary FibrosisOct 15, 2026NCT05255991
- Evaluation of Elexacaftor/Tezacaftor/Ivacaftor (ELX/TEZ/IVA) in Cystic Fibrosis (CF) Participants 12 to Less Than 24 Months of AgeOct 15, 2026NCT05882357
- Study of Carbetocin Nasal Spray for the Treatment of Hyperphagia in Prader-Willi SyndromeOct 15, 2026NCT06173531
- A Study of Adeno-Associated Virus Serotype 8-Mediated Gene Transfer of Glucose-6-Phosphatase in Patients With Glycogen Storage Disease Type Ia (GSDIa)Oct 14, 2026NCT05139316
- A Study of Nivolumab and Relatlimab in Combination With Bevacizumab in Advanced Liver CancerOct 14, 2026NCT05337137
- Brightline-2: A Study to Test Whether Brigimadlin (BI 907828) Helps People With Cancer in the Biliary Tract, Pancreas, Lung or BladderOct 14, 2026NCT05512377
- Cryoablation for Monomorphic Ventricular Tachycardia (CryoCure-VT)Oct 13, 2026NCT04893317
- Luveltamab Tazevibulin (STRO-002) in Infants and Children < 12 Years of Age With Relapsed/Refractory CBFA2T3::GLIS2 AMLOct 13, 2026NCT06679582
Stopped19
- An Open Label Extension (OLE) Study to Evaluate Long-term Safety and Tolerability of Pelacarsen (TQJ230)TerminatedNov 10, 2026NCT05900141
- Long-term Extension of GTX-102 in Angelman SyndromeTerminatedNov 3, 2026NCT06415344
- Phase 3 Efficacy and Safety Study of GTX-102 in Pediatric Subjects With Angelman Syndrome (AS)TerminatedNov 3, 2026NCT06617429
- A Study to Learn About the Study Medicine (Called PF-07868489) in People With Pulmonary Arterial Hypertension Who Have Previously Participated in a Clinical Study With PF-07868489TerminatedNov 2, 2026NCT07073820
- An Open-label Extension Safety Study of MELAS Patients Who Completed TIS6463-203 (PRIZM)TerminatedOct 30, 2026NCT06961344
Show 14 moreShow fewer
- A Study Evaluating the Efficacy of Xanomeline/Trospium (XT) on Cognitive Impairment After 24 and 52 Weeks of Treatment in Adult Participants With SchizophreniaWithdrawnOct 30, 2026NCT07084831
- Phase 1/2 Study Evaluating MCLA-129, a Human Anti-EGFR, Anti-c-MET Bispecific Antibody, in Advanced NSCLC and Other Solid Tumors, Alone and in CombinationTerminatedOct 26, 2026NCT04868877
- Prevention of Symptomatic Skeletal Events With Denosumab Administered Every 4 Weeks Versus Every 12 WeeksTerminatedOct 23, 2026NCT02051218
- Platform Study of JDQ443 in Combinations in Patients With Advanced Solid Tumors Harboring the KRAS G12C MutationTerminatedOct 21, 2026NCT05358249
- A Study to Investigate Efficacy and Safety of SAR441566 in Patients With Ulcerative ColitisTerminatedOct 21, 2026NCT06867094
- Baroloop Multicenter Trial (Baroloop MCT)TerminatedOct 20, 2026NCT06518915
- Phase 1 Single Ascending Doses (SAD) of M5542 in Healthy ParticipantsSuspendedOct 20, 2026NCT06577337
- A Study of Botensilimab (AGEN1181) for the Treatment of Advanced MelanomaTerminatedOct 19, 2026NCT05529316
- Study to Explore the Safety, Tolerability, and Pharmacokinetics of AMG 305 in Subjects With Advanced Solid TumorsTerminatedOct 19, 2026NCT05800964
- ADAPT Study: Long-term Safety Study of INZ-701 in Patients With ENPP1 Deficiency and ABCC6 DeficiencyTerminatedOct 19, 2026NCT06462547
- Improvement of Quality of Life by Cannabinoids in Oncologic PatientsTerminatedOct 16, 2026NCT06097533
- Study of Efficacy and Safety of LNP023 in Participants With Active Lupus Nephritis Class III-IV, +/- VTerminatedOct 15, 2026NCT05268289
- Radioimmunotherapy With Lu-177 Labeled 6A10 Fab-fragments in Patients With Glioblastoma After Standard TreatmentTerminatedOct 13, 2026NCT05533242
- A Study to Investigate Efficacy and Safety of SAR441566 in Patients With Crohn's Disease.TerminatedOct 13, 2026NCT06637631
Newly registered63
- A Study to Test Obrixtamig Treatment in People With Different Types of Advanced Cancer Who Took Part in a Previous Study With ObrixtamigNov 10, 2026NCT07929051
- Focal Pulsed Field Ablation of Ventricular TachycardiaNov 10, 2026NCT07929545
- AI-Based Tools for Stroke Diagnosis, Treatment and Outcome Prediction: a Multicentre Prospective Observational StudyNov 9, 2026NCT07924371
- Transarterial Chemoembolization (TACE) and Stereotactic Body Radiation (SBRT) in Patients With Hepatocellular Carcinoma (HCC) Prior to Liver TransplantationNov 9, 2026NCT07924943
- Exercise and Protein to Reduce Muscle Loss During GLP-1-Based Treatment in Type 2 DiabetesNov 9, 2026NCT07926152
Show 45 moreShow fewer
- A Study to Test Whether BI 3810477 Helps People With Idiopathic Pulmonary Fibrosis When Taken With or Without Standard TreatmentNov 9, 2026NCT07926321
- Whole-Body Electromyostimulation and Speed ClimbingNov 9, 2026NCT07926932
- Assessment of Communication Interventions on Vaccination Knowledge and AcceptanceNov 6, 2026NCT07921121
- A Prospective, Open-label, Randomized, Multicenter Phase-III Trial to Evaluate the Efficacy of Pirtobrutinib and Epcoritamab Compared With R-(Mini)-CHOP for Treatment of Patients With DLBCL-type Richter TransformationNov 5, 2026NCT07917780
- Localized Aeroallergen Exposure in Atopic DermatitisNov 5, 2026NCT07918586
- A Research Study to Investigate How Well the Medicine CagriSema Lowers High Blood Pressure in People Living With High Blood Pressure and ObesityNov 5, 2026NCT07919405
- A Study to Learn How Well People With Bronchiectasis Tolerate Continued Treatment With Verducatib After Earlier Studies (AIRTIVITY®-ON)Nov 4, 2026NCT07915219
- High-precision Radiosurgery Followed by Minimally Invasive Surgical Approach in Patients With High-prominence Uveal Melanoma: Modern Radiation Techniques and OutcomesNov 3, 2026NCT07913412
- Multi-biomarkers in DEENov 2, 2026NCT07909382
- Structured Treatment and Resource Efficiency Assessment With Lean Six Sigma Integration for Pulmonary Vein IsolationNov 2, 2026NCT07910370
- Post-Market Registry Study for Vibrant Hearing SolutionsOct 30, 2026NCT07906314
- A Study to Test How Well Different Doses of BI 3821001 Are Tolerated by Healthy PeopleOct 30, 2026NCT07908004
- Cross-cultural Adaptation and Validation of the Localised Scleroderma Quality of Life Instrument (LoSQI) in Juvenile Localised Scleroderma (JLS)Oct 30, 2026NCT07908108
- Magnetic Field Maps With NV Application Kit MCGOct 30, 2026NCT07908173
- Multicenter Study for External Validation of the TB-NET ScoreOct 29, 2026NCT07903532
- ADBest TREAT RegistryOct 29, 2026NCT07904546
- A Study of Eloralintide (LY3841136) in Participants With Obesity or Overweight, Type 2 Diabetes, and Increased Cardiovascular RiskOct 28, 2026NCT07900633
- Register for Medical Data, Functional Scales, and Care Outcomes in ALS, SMA, and Other Motor System DisordersOct 28, 2026NCT07900672
- Monitoring and Early Detection of Treatable Inherited RETinal Disease in Children and AdolescentsOct 28, 2026NCT07901907
- Mi2000 TICI Follow-upOct 28, 2026NCT07902414
- AI-generated Treatment Recommendations in Precision OncologyOct 27, 2026NCT07897110
- Evaluating the Effects of the EXOPULSE Suit on Mobility, Walking Ability, and Balance in People With Multiple SclerosisOct 27, 2026NCT07897760
- Exercise and Fall Prevention for Fracture ReductionOct 27, 2026NCT07897929
- GD2IL18CART Combined With Bevacizumab for Relapsed and Refractory GD2-positive Solid TumorsOct 27, 2026NCT07897968
- Early Rehabilitation After Transfemoral Amputation in Moderately Active Patients Using the Avior KneeOct 27, 2026NCT07898098
- A Study to Assess the Efficacy and Safety of Pegcetacoplan for the Prevention of Recurrent C3G or Primary IC-MPGN in Kidney Transplant RecipientsOct 27, 2026NCT07898774
- Safety, Tolerability And Pharmacodynamics of DM-101PX in Birch Pollen AllergyOct 27, 2026NCT07898800
- A Research Study to Check the Safety of NNC9836-0001 When Given to Healthy Participants and Participants With Type 2 DiabetesOct 26, 2026NCT07896109
- LIfestyle MEtabotype Study B (LIME-B)Oct 22, 2026NCT07888257
- Assessment of Intelligent Algorithms for Detection, Diagnosis and Risk Stratification of Tumors of the Kidney and ProstateOct 22, 2026NCT07888322
- Effectiveness and Safety of the RIGHTEST™ CGM System for Blood Glucose Management in Persons With Diabetes MellitusOct 22, 2026NCT07888582
- IDH1-vac in Patients With Newly Diagnosed IDH1R132H-positive High-grade AstrocytomasOct 22, 2026NCT07888647
- Evaluation of Safety, Performance and Usability of the TR Band DISTAL Device for Hemostasis Following Distal Radial Access in Coronary ProceduresOct 22, 2026NCT07888738
- RIGHTEST iFree 2 CGM in Pregnant Women With Diabetes StudyOct 22, 2026NCT07889388
- Sensation Seeking and TMS Response in TRDOct 22, 2026NCT07889739
- HUGO-SLEEVE: Evaluating the Feasibility of Robotic Sleeve Gastrectomy With a New PlatformOct 21, 2026NCT07884994
- Deep Repetitive Transcranial Magnetic Stimulation in the Treatment of TinnitusOct 21, 2026NCT07885176
- Long-Term Cognitive Recovery After Arteria Cerebri Media Ischemia: A Digital Assessment Using the TuCAN-AppOct 21, 2026NCT07885189
- Upper Airway Morphology and Physiology During Graded Positive Pressure and Nasal High Flow: An MRI StudyOct 21, 2026NCT07886502
- Microneedle-based ISF Sampling TechniqueOct 20, 2026NCT07882225
- Study With Batten-1 (Miglustat Liquid Formulation) to Treat Ceroid Lipofuscinosis Neuronal 3 (CLN3) DiseaseOct 20, 2026NCT07882290
- Multimodal Characterization of Movement Trajectories in Chronic Inflammatory Demyelinating PolyneuropathyOct 20, 2026NCT07882797
- Improving Combined PET/CT and MRI of the Breast Using Dedicated Breast Positioning and Image RegistrationOct 20, 2026NCT07883460
- Development and Multi-Centre Validation of a Novel Non-Invasive Melanoma Molecular Diagnostic TestOct 20, 2026NCT07883954
- Respiratory Viral Infections Following Oktoberfest AttendanceOct 19, 2026NCT07879781
and 13 more not listed
Studies
Recruiting first, then most recently updated. Showing 50 of 28,747 — search for more.
- A Long-term Extension Study to Assess the Long-term Safety and Efficacy of Pegtibatinase Treatment in Participants ≥5 to ≤65 Years of Age With Classical Homocystinuria (HCU) (ENSEMBLE) (ENSEMBLE)Enrolling by invitationNCT06431893Phase 3
- Effects of rTMS Compared to SSRI as Early Treatment of Depression (Early-TMS)RecruitingNCT06545474Not applicable
- An Open-Label Extension Study to Evaluate the Safety and Tolerability of SPT-300 (GlyphAllo) in Participants With Major Depressive Disorder, With or Without Anxious Distress (BUOY-1 OLE Study)Enrolling by invitationNCT07161700Phase 2
- A Study to Compare the Efficacy and Safety of BMS-986489 (Atigotatug+ Nivolumab Fixed Dose Combination) in Combination With Carboplatin Plus Etoposide to That of Atezolizumab With Carboplatin Plus Etoposide as First-Line Therapy in Participants With Extensive-Stage Small Cell Lung Cancer (TIGOS).RecruitingNCT06646276Phase 3
- Focal Pulsed Field Ablation of Ventricular TachycardiaEnrolling by invitationNCT07929545
- A Study to Evaluate the Efficacy and Safety of QVM149 (Indacaterol Acetate / Glycopyrronium Bromide / Mometasone Furoate) Versus Salmeterol Xinafoate/Fluticasone Propionate in Children From 12 Years to Less Than 18 Years of Age With Asthma.RecruitingNCT05776927Phase 3
- A Study to Test Obrixtamig Treatment in People With Different Types of Advanced Cancer Who Took Part in a Previous Study With ObrixtamigNot yet recruitingNCT07929051Phase 3
- Long-term Safety and Efficacy Extension Study for Participants With Advanced Tumors Who Are Currently on Treatment or in Follow-up in a Pembrolizumab (MK-3475) Study (MK-3475-587/KEYNOTE-587)RecruitingNCT03486873Phase 3
- Safety, Tolerability, Pharmacokinetics, and Preliminary Efficacy of SPL84 in Patients With Cystic FibrosisRecruitingNCT06429176Phase 2
- LUNAR-2: TTFields With Pembrolizumab + Platinum-based Chemotherapy for Metastatic NSCLCRecruitingNCT06216301Phase 3
- A Study to Evaluate the Efficacy and Safety of Tulisokibart (MK-7240) in Participants With Moderate to Severe Crohn's Disease (MK-7240-008)RecruitingNCT06430801Phase 3
- A Study of Calderasib (MK-1084) Plus Pembrolizumab (MK-3475) in Participants With KRAS G12C Mutant Non-small Cell Lung Cancer (NSCLC) With Programmed Cell Death Ligand 1 (PD-L1) Tumor Proportion Score (TPS) ≥50% (MK-1084-004/KANDLELIT-004)RecruitingNCT06345729Phase 3
- A Clinical Study of the Anti-cancer Effects of an Investigational Therapy or Chemotherapy in Patients With Recurring Uterine CancerRecruitingNCT06340568Phase 3
- The PERSEVERE StudyRecruitingNCT06588634Not applicable
- A Phase 2 Efficacy and Safety Study of GAL-101, 2% Ophthalmic Solution in Non-foveal Geographic Atrophy Secondary to Non-neovascular AMDRecruitingNCT06659549Phase 2
- Belzutifan/MK-6482 for the Treatment of Advanced Pheochromocytoma/Paraganglioma (PPGL), Pancreatic Neuroendocrine Tumor (pNET), Von Hippel-Lindau (VHL) Disease-Associated Tumors, Advanced Gastrointestinal Stromal Tumor (wt GIST), or Solid Tumors With HIF-2α Related Genetic Alterations (MK-6482-015)RecruitingNCT04924075Phase 2
- Beamion PANTUMOR-1: A Study to Test Whether Zongertinib Helps People With Advanced Cancers With HER2 AlterationsRecruitingNCT06581432Phase 2
- Dabrafenib and/or Trametinib Rollover StudyRecruitingNCT03340506Phase 4
- VT Ablation in the iCMRRecruitingNCT05543798Not applicable
- A Study of Sacituzumab Tirumotecan (Sac-TMT, MK-2870) as Monotherapy and in Combination With Pembrolizumab (MK-3475) in Participants With Triple-Negative Breast Cancer (MK-2870-011/TroFuse-011)RecruitingNCT06841354Phase 3
- A Study to Learn About How Safe BAY 3389934 is, Its Suitable Dose, and How it Affects the Participants With Sepsis Induced CoagulopathyRecruitingNCT06854640Phase 1
- A Clinical Study of Sacituzumab Tirumotecan (Sac-TMT, MK-2870) in People With Breast Cancer (MK-2870-032)RecruitingNCT06966700Phase 3
- A Study to Compare Sacituzumab Tirumotecan (MK-2870) in Combination With Pembrolizumab (MK-3475) Versus Pembrolizumab Alone as Treatment in Participants With Mismatch Repair Proficient Endometrial Cancer (MK-2870-033/TroFuse-033/GOG-3119/ENGOT-en29)RecruitingNCT06952504Phase 3
- A Study to Assess Efficacy and Safety of Pembrolizumab With or Without Sacituzumab Tirumotecan (MK- 2870) in Adult Participants With Resectable Non Small Cell Lung Cancer (NSCLC) Not Achieving Pathological Complete Response (pCR) (MK-2870-019)RecruitingNCT06312137Phase 3
- Efficacy, Safety, and Pharmacokinetics of Vericiguat in Pediatric Participants With Heart Failure Due to Left Ventricular Systolic Dysfunction (MK-1242-036)RecruitingNCT05714085Phase 2/3
- EPIK-P4: A Phase II Single-arm Study to Assess the Efficacy, Safety and Pharmacokinetics of Alpelisib (BYL719) in Pediatric and Adult Patients With PIK3CA-related Overgrowth Spectrum (PROS)RecruitingNCT06997588Phase 2
- Study of Volrustomig in Women With High Risk Locally Advanced Cervical Cancer (eVOLVE-Cervical)RecruitingNCT06079671Phase 3
- Evaluate Optimization of CRS Profile for Glofit Monotherapy and Glofit+GemOx in R/R Aggressive B-NHLRecruitingNCT06806033Phase 2
- An Open-Label Extension Study of Treprostinil Palmitil Inhalation Powder (TPIP) in Participants With Pulmonary Hypertension Associated With Interstitial Lung Disease (PH-ILD)RecruitingNCT07234032Phase 3
- A Study of KarXT + KarX-EC for Treatment of Irritability in Children and Adolescents With Autism Spectrum DisorderRecruitingNCT07285798Phase 3
- Phase III Study of Datopotamab Deruxtecan Versus Docetaxel in Previously Treated TROP2-positive Advanced or Metastatic Non-squamous NSCLC Without Actionable Genomic AlterationsRecruitingNCT07291037Phase 3
- Study on Hydrotalcite for Relief of Acid Symptoms Due to Acid Rebound After Stopping Long-Term PPI TherapyRecruitingNCT07291700
- A Phase 2 Study to Investigate the Efficacy, Safety and Tolerability of Remibrutinib (LOU064) in Adult Patients With Papulopustular Rosacea (PPR)RecruitingNCT07681271Phase 2
- Prevention of Recurrent C. Difficile Infection Study With AZD5148 Monoclonal AntibodyRecruitingNCT07285213Phase 2
- Study of Izalontamab Brengitecan (BMS-986507) in Combination With Osimertinib Versus Osimertinib Monotherapy or Osimertinib in Combination With Platinum-based Chemotherapy for EGFRmt Non-small Cell Lung Cancer (IZABRIGHT-Lung02)RecruitingNCT07680790Phase 3
- Rollover Study for Participants Who Have Completed a Previous Clinical Study With Anifrolumab (Saphnelo) and Clinically Benefited From Continued TreatmentRecruitingNCT07691970Phase 3
- A Phase 3 Study to Evaluate the Safety and Efficacy of AOC 1044 (Also Referred to as Delpacibart Zotadirsen) in Participants With DMD With Gene Mutations Amenable to Exon 44 SkippingRecruitingNCT07587242Phase 3
- Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of OJR520 in Healthy Volunteers and Participants With Chronic Kidney DiseaseRecruitingNCT07235059Phase 1
- A Study to Evaluate the Efficacy and Safety of SPT-300 (GlyphAllo) in Participants With Major Depressive Disorder, With or Without Anxious Distress (BUOY-1 Study)RecruitingNCT07065240Phase 2
- DAREON ® -Lung-1: A Study in People With Advanced Small Cell Lung Cancer to Compare Obrixtamig Plus Atezolizumab, Carboplatin, and Etoposide Treatment With Standard ChemoimmunotherapyRecruitingNCT07472517Phase 3
- A Phase 3 Study of Pelabresib (DAK539) and Ruxolitinib in Myelofibrosis (MF)RecruitingNCT07357727Phase 3
- Cevostamab in Combination With Pomalidomide and Dexamethasone Versus Standard of Care in Participants With Previously Treated Multiple MyelomaRecruitingNCT07555938Phase 3
- Study of an Injectable Regimen of GS-3242 With Lenacapavir Compared to Biktarvy in People New to HIV-1 TreatmentRecruitingNCT07708727Phase 2/3
- A Study to Evaluate the Treatment Outcomes of Subcutaneous Anifrolumab in Immunosuppressant-naïve and Biologic-naïve Systemic Lupus ErythematosusRecruitingNCT07430306Phase 3
- DAREON®-NEC-1: A Study in People With Advanced Extrapulmonary Neuroendocrine Cancer (epNEC) to Compare Obrixtamig Plus Carboplatin and Etoposide Treatment With Standard ChemotherapyRecruitingNCT07544654Phase 3
- Visugromab, Nivolumab and Lenvatinib Compared to Double Placebo and Lenvatinib in Unresectable or Metastatic Hepatocellular Carcinoma Post Anti-PD-(L)1 FailureRecruitingNCT07219459Phase 2
- A Study in Pediatric Participants With Congenital Adrenal Hyperplasia (Balance-CAH)RecruitingNCT07159841Phase 2/3
- A Study of GSK5764227 in Participants With Relapsed Small Cell Lung Cancer (SCLC) [EMBOLD SCLC-301]RecruitingNCT07099898Phase 3
- A Study to Find Out How Nerandomilast is Tolerated, Handled by the Body, and if it Helps Children and Adolescents With Interstitial Lung Disease (FIBRONEER-chILD)RecruitingNCT07366034Phase 3
- A Clinical Study of Belzutifan (MK-6482) and Zanzalintinib in People With Renal Cell Carcinoma (RCC) (LITESPARK-034/LS-034/MK-6482-034)RecruitingNCT07489495Phase 3